These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36424174)

  • 1. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
    Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
    Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
    Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
    Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Properties of Thrombus-Targeted Urokinase/Multi-Walled Carbon Nanotubes (MWCNTs)-Chitosan (CS)-RGD Drug Delivery System.
    Zhang R; Luo S; Hao LK; Jiang YY; Gao Y; Zhang NN; Zhang XC; Song YM
    J Biomed Nanotechnol; 2021 Sep; 17(9):1711-1725. PubMed ID: 34688316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microenvironment responsive crosslinking cyclodextrin metal-organic framework nanocarriers for precise targeting and thrombolysis.
    Yuan C; Ye Y; Hu E; Xie R; Lu B; Yu K; Ding W; Wang W; Lan G; Lu F
    Carbohydr Polym; 2024 Jun; 334():122058. PubMed ID: 38553243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles.
    Shan L; Wang J; Tu H; Zhang W; Li H; Slezak P; Lu F; Lee D; Hu E; Geng Z; Lan G; Xie R
    Carbohydr Polym; 2024 Nov; 343():122505. PubMed ID: 39174110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-
    Chen S; Liang M; Wu C; Zhang X; Wang Y; Zhao M
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Davidson DJ; Lubbers NL; Reininger IM; Henkin J
    Thromb Res; 1996 Sep; 83(6):421-31. PubMed ID: 8885137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.
    Xie S; Mo C; Cao W; Xie S; Li S; Zhang Z; Li X
    Acta Biomater; 2022 Apr; 142():49-59. PubMed ID: 35158079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis.
    Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y
    Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic Biotaxi Solution Based on Blood Cell Membrane Cloaking Enables Fullerenol Thrombolysis
    Chen K; Wang Y; Liang H; Xia S; Liang W; Kong J; Liang Y; Chen X; Mao M; Chen Z; Bai X; Zhang J; Li J; Chang YN; Li J; Xing G
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14958-14970. PubMed ID: 32142246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy.
    Xie S; Li S; Cao W; Mo C; Zhang Z; Huang K; Li X
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37553-37565. PubMed ID: 35948498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Propelled Janus Rod-Shaped Micromotors for Site-Specific Sonodynamic Thrombolysis.
    Cao W; Liu Y; Ran P; He J; Xie S; Weng J; Li X
    ACS Appl Mater Interfaces; 2021 Dec; 13(49):58411-58421. PubMed ID: 34846117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
    Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
    J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
    Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
    Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.
    Chen Z; Yuan C; Ye Y; Lu B; Hu E; Lu F; Yu K; Xie R; Lan G
    Carbohydr Polym; 2024 Mar; 328():121703. PubMed ID: 38220339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
    Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GOx-Powered Janus Platelet Nanomotors for Targeted Delivery of Thrombolytic Drugs in Treating Thrombotic Diseases.
    Fang X; Ye H; Shi K; Wang K; Huang Y; Zhang X; Pan J
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4302-4310. PubMed ID: 37307138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.